Business
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Revenues of $185,471 for the Quarter Ended September 30, 2022, as Compared to $ 28,082 for the Quarter Ended September 30, 2021, an increase of over 600%
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Revenues of $185,471 for the Quarter Ended September 30, 2022, as Compared to $ 28,082 for the Quarter Ended September 30, 2021, an increase of over 600%.
About this update from Emergent Health Corp.
[{"type":"text","content":"HAUPPAUGE, NY / ACCESSWIRE / November 21, 2022 / Emergent Health Corp. (OTC PINK:EMGE) announced Revenues of $185,471 for the Quarter Ended September 30, 2022, as Compared to $ 28,082 for the Quarter Ended September 30, 2021, an increase of over 600%. The financial statement can be viewed in its entirety at OTC Markets.Former L'Oréal President and Emergents new full time CEO stated "I am pleased, but not satisfied with the Revenue achieved in my 1st quarter as CEO of Emergent. We intend to expand our operations both internally and externally through strategic acquisitions, adding new product lines through innovative marketing initiatives and increasing our footprint in the Regenerative Health Care marketplace. We're looking forward to the upcoming holiday season, historically my busiest and most successful time of year."Our collaboration with "Aesthetics by Design" is changing the landscape for regenerative medicine with our launch of revolutionary innovative products into new retail outlets and by developing new partnerships. Emergent projects to substantially increase revenues this quarter ending December 31st, 2022.The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030. A biologic medication is a product that is made from live organisms and contains living organism components. Recombinant protein, tissues, allergens, genes, cells, blood components, blood, and vaccinations are all examples of biologics. Anemia, hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis, inflammatory bowel disease, and other disorders and infections are treated with biologics. Various government efforts, higher share of biologics in the market, and rising use of biopharmaceuticals over chemically produced molecules, and many other factors are driving the biologics market expansion in the forecast period.ABOUT EMERGENT HEALTH CORPORATIONEmergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsi...